PCSK9 Promotes Cardiovascular Diseases: Recent Evidence about Its Association with Platelet Activation-Induced Myocardial Infarction
Cardiovascular diseases are the leading cause of death worldwide, with the majority of the cases being heart failure due to myocardial infarction. Research on cardiovascular diseases is currently underway, particularly on atherosclerosis prevention, to reduce the risk of myocardial infarction. Propr...
Main Authors: | Meidi Utami Puteri, Nuriza Ulul Azmi, Mitsuyasu Kato, Fadlina Chany Saputri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/2/190 |
Similar Items
-
Recent Update on PCSK9 and Platelet Activation Experimental Research Methods: In Vitro and In Vivo Studies
by: Meidi Utami Puteri, et al.
Published: (2022-08-01) -
The role of modern antithrombotic agents in cardiovascular disease prevention
by: O. M. Drapkina, et al.
Published: (1970-01-01) -
Prospects of Using PCSK9 Inhibitors for Acute Coronary Syndrome
by: A. M. Namitokov, et al.
Published: (2024-04-01) -
Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia1
by: Kiyohito Arai, et al.
Published: (2012-08-01) -
Relationship Between Coronary Atheroma, Epicardial Adipose Tissue Inflammation, and Adipocyte Differentiation Across the Human Myocardial Bridge
by: Tracey McLaughlin, et al.
Published: (2021-11-01)